← Search & browse all drugs
NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Benzodiazepine derivatives
dimdazenil
N05CD16
Forms & Strengths
- Experimental formulation
- Oral tablets (investigational)
Adult Dosing
- Investigational drug; no standard clinical adult dosing established
- Evaluated in clinical trials for anxiety and cognitive disorders at variable titrated doses
Pediatric Dosing
- Not established for pediatric use
Indications
- Investigated as an anxiolytic
- Studied for cognitive enhancement properties
Mechanism of Action
- Partial agonist at the benzodiazepine site of the GABAA receptor
- Exhibits high affinity for central benzodiazepine receptors with low intrinsic efficacy
Contraindications
- Hypersensitivity to dimdazenil or benzodiazepine class compounds
- Severe hepatic impairment
- Acute narrow-angle glaucoma
Adverse Reactions
- Somnolence
- Dizziness
- Headache
- Fatigue
- Mild sedation
Drug Interactions
- CNS depressants (alcohol, opioids, barbiturates) may enhance sedative effects
- CYP3A4 inhibitors or inducers may alter plasma concentrations
Curated Content: Needs Vetting Before Put to Clinical Use